Skip Navigation

European Journal of Heart Failure 2005 7(5):865-868; doi:10.1016/j.ejheart.2004.09.014
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sharma, R.
Right arrow Articles by Anker, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, R.
Right arrow Articles by Anker, S. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 European Society of Cardiology

Cellular endotoxin desensitization in patients with severe chronic heart failure

Rakesh Sharmaa,1, Aidan P. Bolgera,1, Mathias Rauchhausa,b,1, Stephan von Haehlinga,1, Wolfram Doehnera,b, Ian M. Adcockc, Peter J. Barnesc, Philip A. Poole-Wilsona, Hans-Dieter Volkd, Andrew J.S. Coatsa, Sam Limc and Stefan D. Ankera,b,*

a Clinical Cardiology, NHLI Imperial College School of Medicine, London, UK
b Division of Applied Cachexia Research Department of Cardiology, Charité Medical School, Berlin, Germany
c Thoracic Medicine, NHLI Imperial College School of Medicine, London, UK
d Department of Clinical Immunology Charité Campus Mitte, Berlin, Germany

* Corresponding author. Department of Clinical Cardiology, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK. Tel.: +44 20 7351 8203; fax: +44 20 7351 8733. E-mial address: s.anker{at}imperial.ac.uk


   Abstract

Background: Increased levels of bacterial lipopolysaccharide (LPS) have been demonstrated in chronic heart failure (CHF). LPS can induce cellular desensitization, with specific down-regulation of LPS-mediated cellular tumor necrosis factor (TNF-{alpha}) production which does not affect other cytokine parameters. It is not known if LPS desensitization occurs in CHF.

Methods and results: Mononuclear cells from 24 CHF patients (mean age 70±2 years, age range 58 to 78 years, NYHA class 3.0±0.2) and 11 healthy controls (mean age 53±3 years, age range 39 to 75 years) were separated from venous blood and cultured for 24 h with LPS (E. coli, 0–10 ng/mL). Culture supernatants were tested for TNF-{alpha} and interleukin-1 receptor antagonist (IL-1RA). Patients were subgrouped into mild (n=10), moderate (n=5), and severe (n=9) CHF. Independently of age, mononuclear cells from patients with severe heart failure produced less TNF-{alpha} than controls (p<0.05) and patients with mild (p<0.001) or moderate CHF (p<0.05). IL-1RA release was higher for CHF patients as a group, compared with controls (p<0.05). There was no significant difference in IL-1RA release between CHF patient subgroups.

Conclusions: Mononuclear cells from patients with severe heart failure produce significantly less TNF-{alpha} than healthy controls or patients with mild to moderate disease. Production of IL-1RA is not affected. This resembles a picture indicative of LPS desensitization occurring in patients with severe CHF.

Key Words: Heart failure • Lipopolysaccharide • Cytokines

Received January 5, 2004; Revised June 8, 2004; Accepted September 20, 2004


1 Rakesh Sharma, Aidan P. Bolger, Mathias Rauchhaus and Stephan von Haehling contributed equally to the work in this manuscript.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.